Momentum investing is essentially an exception to the idea of "buying low and selling high." Investors following this style of investing are usually not interested in betting on cheap stocks and waiting long for them to recover. Instead, they believe that "buying high and selling higher" is the way to make far more money in lesser time.Everyone likes betting on fast-moving trending stocks, but it isn't easy to determine the right entry point. These stocks often lose momentum when their future growth potenti ...

Core Viewpoint - Aveanna Healthcare (AVAH) is experiencing significant improvements in earnings estimates, which may lead to continued stock price momentum [1][2] Estimate Revisions - The trend in estimate revisions reflects growing analyst optimism regarding Aveanna's earnings prospects, which is expected to positively impact its stock price [2] - For the current quarter, Aveanna is projected to earn $0.06 per share, marking a 200.0% increase from the previous year [6] - Over the last 30 days, the Zacks Consensus Estimate for Aveanna has surged by 850%, with three estimates moving higher and no negative revisions [6] - For the full year, the earnings estimate is $0.35 per share, representing a 483.3% increase from the prior year [7] - The consensus estimate for the current year has increased by 195.35% during this period [8] Zacks Rank - Aveanna has achieved a Zacks Rank 1 (Strong Buy) due to favorable estimate revisions, indicating strong potential for stock performance [9] - The Zacks Rank system has a proven track record, with Zacks 1 Ranked stocks generating an average annual return of +25% since 2008 [3] Stock Performance - Aveanna's stock has gained 80.9% over the past four weeks, driven by solid estimate revisions and positive earnings growth prospects [10]

Core Viewpoint - Momentum investing focuses on "buying high and selling higher" rather than the traditional "buying low and selling high" approach, aiming for quicker profits [1] Group 1: Momentum Investing Characteristics - Momentum investing can be risky as stocks may lose momentum if their valuations exceed future growth potential, leading to potential losses for investors [2] - A safer strategy involves investing in bargain stocks that exhibit recent price momentum, utilizing tools like the Zacks Momentum Style Score to identify such opportunities [3] Group 2: Aveanna Healthcare (AVAH) Analysis - Aveanna Healthcare (AVAH) has shown significant price movement, with a 74.7% increase over the past four weeks, indicating strong investor interest [4] - Over the past 12 weeks, AVAH's stock has gained 32.3%, demonstrating its ability to maintain momentum over a longer period [5] - AVAH has a beta of 1.95, suggesting it moves 95% more than the market, indicating fast-paced momentum [5] - The stock has a Momentum Score of B, suggesting it is an opportune time for investment to capitalize on its momentum [6] - AVAH has received a Zacks Rank 1 (Strong Buy) due to upward revisions in earnings estimates, which typically attract more investors [7] - The stock is currently trading at a Price-to-Sales ratio of 0.68, indicating it is undervalued, as investors pay only 68 cents for each dollar of sales [7] Group 3: Additional Investment Opportunities - Besides AVAH, there are other stocks that meet the criteria of the 'Fast-Paced Momentum at a Bargain' screen, presenting further investment opportunities [8] - Investors can explore over 45 Zacks Premium Screens tailored to different investing styles to identify potential winning stocks [9]

Core Viewpoint - Momentum investing focuses on "buying high and selling higher" rather than traditional strategies of "buying low and selling high" [1] Group 1: Momentum Investing Strategy - Momentum investors often face challenges in determining the right entry point, as stocks may lose momentum when their valuations exceed future growth potential [2] - A safer approach involves investing in bargain stocks that exhibit recent price momentum, utilizing tools like the Zacks Momentum Style Score to identify such opportunities [3] Group 2: Aveanna Healthcare (AVAH) Analysis - Aveanna Healthcare (AVAH) has shown significant recent price momentum, with a four-week price change of 20.3%, indicating growing investor interest [4] - Over the past 12 weeks, AVAH's stock has gained 17.4%, and it has a beta of 2.01, suggesting it moves 101% higher than the market in either direction [5] - AVAH has a Momentum Score of B, indicating a favorable time to invest based on momentum [6] - The stock has received a Zacks Rank 2 (Buy) due to upward trends in earnings estimate revisions, which attract more investor interest [7] - AVAH is trading at a Price-to-Sales ratio of 0.50, suggesting it is undervalued at 50 cents for each dollar of sales [7] Group 3: Additional Investment Opportunities - Besides AVAH, there are other stocks that meet the criteria of the 'Fast-Paced Momentum at a Bargain' screen, presenting further investment opportunities [8] - The Zacks Premium Screens offer over 45 strategically created options to help investors find winning stock picks [9]